the false-negative rate for negative ea-rosette tests was 3.7 % for invasive carcinoma , 17.5 % for carcinoma in situ and severe dysplasia and 41.4 % for mild to moderate dysplasia .
C0007099
carcinoma in situ
C0334048
severe dysplasia